Last reviewed · How we verify

NCT05377073

Effects of Complementary Therapies in People With Mild to Moderate Parkinson's Disease

Completed NA Last updated 17 May 2022
What this trial tests

NA trial testing Hatha Yoga in Parkinson Disease in 24 participants. Completed in 14 January 2022.

Timeline
14 September 2021
Primary endpoint
22 October 2021
14 January 2022

Quick facts

Lead sponsorUniversity of the Basque Country (UPV/EHU)
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment24
Start date14 September 2021
Primary completion22 October 2021
Estimated completion14 January 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of the Basque Country (UPV/EHU)

Who can join

45 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to compare the effects of Hatha Yoga versus Stretching on physical outcomes, quality of life, physical activity and motor examination in persons with Parkinson Disease. The hypothesis of this study is that Hatha Yoga will improve more than Stretching on physical outcomes, quality of life, physical activity and on motor examinations in persons with parkinson Diseases

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Hatha Yoga

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other University of the Basque Country (UPV/EHU) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05377073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing